HIVE vs AXG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 16, 2026

HIVE

52.3
AI Score
VS
AXG Wins

AXG

59.9
AI Score

Investment Advisor Scores

HIVE

52score
Recommendation
HOLD

AXG

60score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HIVE AXG Winner
Revenue 297.79M 2.82M HIVE
Net Income -148.45M -8.54M AXG
Net Margin -49.8% -302.9% HIVE
ROE -28.0% -180.5% HIVE
ROA -23.2% -69.4% HIVE
Total Assets 639.15M 12.31M HIVE
Cash 23.11M 3.84M HIVE
Current Ratio 1.10 1.29 AXG

Relative Price Performance (Last 90 Days)

HIVE 1M: -18.2% · 3M: +17.4% AXG 1M: -7.1% · 3M: -23.2%

Current Technical Phase

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 42.0 · Price: $2.83

AXG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.3%), weak momentum, RSI 26

RSI (14): 25.7 · Price: $3.02

Fundamentals Snapshot

Metric HIVE AXG
Market Cap
Forward P/E -5.5 0.0
Trailing P/E
Revenue (TTM)
Revenue Growth 1.3% 3.0%
Gross Margin 0.4% 0.9%
Operating Margin -0.8% 0.0%
EPS -0.78 -0.20
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, AXG is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.